ID   TNR6A_HUMAN             Reviewed;        1962 AA.
AC   Q8NDV7; C9JAR8; O15408; Q658L5; Q6NVB5; Q8NEZ0; Q8TBT8; Q8TCR0; Q9NV59;
AC   Q9P268;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   11-DEC-2019, entry version 177.
DE   RecName: Full=Trinucleotide repeat-containing gene 6A protein;
DE   AltName: Full=CAG repeat protein 26;
DE   AltName: Full=EMSY interactor protein;
DE   AltName: Full=GW182 autoantigen;
DE            Short=Protein GW1;
DE   AltName: Full=Glycine-tryptophan protein of 182 kDa;
GN   Name=TNRC6A; Synonyms=CAGH26, KIAA1460, TNRC6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), RNA-BINDING, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11950943; DOI=10.1091/mbc.01-11-0544;
RA   Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K.,
RA   Fritzler M.J.;
RT   "A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique
RT   population of human mRNAs within novel cytoplasmic speckles.";
RL   Mol. Biol. Cell 13:1338-1351(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Hughes-Davies L.;
RT   "Candidate EMSY interactor protein.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 861-1962 (ISOFORM 6).
RC   TISSUE=Kidney, and Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1515-1962.
RC   TISSUE=Kidney, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-157 (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=9225980; DOI=10.1007/s004390050476;
RA   Margolis R.L., Abraham M.R., Gatchell S.B., Li S.H., Kidwai A.S.,
RA   Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
RT   "cDNAs with long CAG trinucleotide repeats from human brain.";
RL   Hum. Genet. 100:114-122(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-1962.
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1522-1962.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   AUTOANTIGENIC EPITOPE MAPPING.
RX   PubMed=14598044; DOI=10.1007/s00109-003-0495-y;
RA   Eystathioy T., Chan E.K.L., Takeuchi K., Mahler M., Luft L.M.,
RA   Zochodne D.W., Fritzler M.J.;
RT   "Clinical and serological associations of autoantibodies to GW bodies and a
RT   novel cytoplasmic autoantigen GW182.";
RL   J. Mol. Med. 81:811-818(2003).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=13130130; DOI=10.1261/rna.5810203;
RA   Eystathioy T., Jakymiw A., Chan E.K.L., Seraphin B., Cougot N.,
RA   Fritzler M.J.;
RT   "The GW182 protein colocalizes with mRNA degradation associated proteins
RT   hDcp1 and hLSm4 in cytoplasmic GW bodies.";
RL   RNA 9:1171-1173(2003).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15494374; DOI=10.1242/jcs.01477;
RA   Yang Z., Jakymiw A., Wood M.R., Eystathioy T., Rubin R.L., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "GW182 is critical for the stability of GW bodies expressed during the cell
RT   cycle and cell proliferation.";
RL   J. Cell Sci. 117:5567-5578(2004).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15908945; DOI=10.1038/ncb1265;
RA   Sen G.L., Blau H.M.;
RT   "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as
RT   cytoplasmic bodies.";
RL   Nat. Cell Biol. 7:633-636(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH AGO2, AND SUBCELLULAR LOCATION.
RX   PubMed=16284623; DOI=10.1038/ncb1333;
RA   Liu J., Rivas F.V., Wohlschlegel J., Yates J.R. III, Parker R.,
RA   Hannon G.J.;
RT   "A role for the P-body component GW182 in microRNA function.";
RL   Nat. Cell Biol. 7:1261-1266(2005).
RN   [14]
RP   FUNCTION, INTERACTION WITH AGO2, ASSOCIATION WITH SIRNA, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16284622; DOI=10.1038/ncb1334;
RA   Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
RA   Fritzler M.J., Chan E.K.L.;
RT   "Disruption of GW bodies impairs mammalian RNA interference.";
RL   Nat. Cell Biol. 7:1267-1274(2005).
RN   [15]
RP   ERRATUM.
RA   Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
RA   Fritzler M.J., Chan E.K.L.;
RL   Nat. Cell Biol. 8:100-100(2006).
RN   [16]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH MICRORNA.
RX   PubMed=16906129; DOI=10.1038/sj.embor.7400783;
RA   Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "Formation of GW bodies is a consequence of microRNA genesis.";
RL   EMBO Rep. 7:904-910(2006).
RN   [17]
RP   FUNCTION.
RX   PubMed=17671087; DOI=10.1101/gad.1566707;
RA   Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
RT   "Let-7 microRNA-mediated mRNA deadenylation and translational repression in
RT   a mammalian cell-free system.";
RL   Genes Dev. 21:1857-1862(2007).
RN   [18]
RP   ERRATUM.
RA   Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
RL   Genes Dev. 21:2509-2509(2007).
RN   [19]
RP   FUNCTION.
RX   PubMed=17596515; DOI=10.1091/mbc.E07-01-0070;
RA   Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
RA   Chan E.K.L.;
RT   "Small interfering RNA-mediated silencing induces target-dependent assembly
RT   of GW/P bodies.";
RL   Mol. Biol. Cell 18:3375-3387(2007).
RN   [20]
RP   ERRATUM.
RA   Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
RA   Chan E.K.L.;
RL   Mol. Biol. Cell 18:4200-4200(2007).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19056672; DOI=10.1242/jcs.036905;
RA   Li S., Lian S.L., Moser J.J., Fritzler M.L., Fritzler M.J., Satoh M.,
RA   Chan E.K.L.;
RT   "Identification of GW182 and its novel isoform TNGW1 as translational
RT   repressors in Ago2-mediated silencing.";
RL   J. Cell Sci. 121:4134-4144(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH AGO2.
RX   PubMed=18690212; DOI=10.1038/nature07186;
RA   Qi H.H., Ongusaha P.P., Myllyharju J., Cheng D., Pakkanen O., Shi Y.,
RA   Lee S.W., Peng J., Shi Y.;
RT   "Prolyl 4-hydroxylation regulates Argonaute 2 stability.";
RL   Nature 455:421-424(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1470, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=18946079; DOI=10.1091/mbc.E08-08-0796;
RA   Jagannath A., Wood M.J.A.;
RT   "Localization of double-stranded small interfering RNA to cytoplasmic
RT   processing bodies is Ago2 dependent and results in up-regulation of GW182
RT   and Argonaute-2.";
RL   Mol. Biol. Cell 20:521-529(2009).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH AGO2.
RX   PubMed=19304925; DOI=10.1261/rna.1448009;
RA   Zipprich J.T., Bhattacharyya S., Mathys H., Filipowicz W.;
RT   "Importance of the C-terminal domain of the human GW182 protein TNRC6C for
RT   translational repression.";
RL   RNA 15:781-793(2009).
RN   [26]
RP   INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF TRP-313; TRP-345; TRP-370; TRP-420 AND TRP-483.
RX   PubMed=19324964; DOI=10.1261/rna.1229409;
RA   Lian S.L., Li S., Abadal G.X., Pauley B.A., Fritzler M.J., Chan E.K.L.;
RT   "The C-terminal half of human Ago2 binds to multiple GW-rich regions of
RT   GW182 and requires GW182 to mediate silencing.";
RL   RNA 15:804-813(2009).
RN   [27]
RP   INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4.
RX   PubMed=19383768; DOI=10.1261/rna.1606309;
RA   Lazzaretti D., Tournier I., Izaurralde E.;
RT   "The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound
RT   transcripts independently of Argonaute proteins.";
RL   RNA 15:1059-1066(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1585, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1869, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   INTERACTION WITH CNOT1.
RX   PubMed=21981923; DOI=10.1016/j.molcel.2011.09.007;
RA   Braun J.E., Huntzinger E., Fauser M., Izaurralde E.;
RT   "GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA
RT   targets.";
RL   Mol. Cell 44:120-133(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-739; SER-878; SER-991;
RP   SER-1212; SER-1270 AND SER-1890, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   INTERACTION WITH ZC3H12A.
RX   PubMed=26134560; DOI=10.1074/jbc.M114.635870;
RA   Huang S., Liu S., Fu J.J., Tony Wang T., Yao X., Kumar A., Liu G., Fu M.;
RT   "Monocyte chemotactic protein-induced protein 1 and 4 form a complex but
RT   act independently in regulation of interleukin-6 mRNA degradation.";
RL   J. Biol. Chem. 290:20782-20792(2015).
RN   [33]
RP   INTERACTION WITH SND1.
RX   PubMed=28546213; DOI=10.1126/science.aai9372;
RA   Elbarbary R.A., Miyoshi K., Myers J.R., Du P., Ashton J.M., Tian B.,
RA   Maquat L.E.;
RT   "Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes
RT   G1/S phase transition.";
RL   Science 356:859-862(2017).
RN   [34]
RP   INVOLVEMENT IN FAME6, AND TISSUE SPECIFICITY.
RX   PubMed=29507423; DOI=10.1038/s41588-018-0067-2;
RA   Ishiura H., Doi K., Mitsui J., Yoshimura J., Matsukawa M.K., Fujiyama A.,
RA   Toyoshima Y., Kakita A., Takahashi H., Suzuki Y., Sugano S., Qu W.,
RA   Ichikawa K., Yurino H., Higasa K., Shibata S., Mitsue A., Tanaka M.,
RA   Ichikawa Y., Takahashi Y., Date H., Matsukawa T., Kanda J., Nakamoto F.K.,
RA   Higashihara M., Abe K., Koike R., Sasagawa M., Kuroha Y., Hasegawa N.,
RA   Kanesawa N., Kondo T., Hitomi T., Tada M., Takano H., Saito Y., Sanpei K.,
RA   Onodera O., Nishizawa M., Nakamura M., Yasuda T., Sakiyama Y., Otsuka M.,
RA   Ueki A., Kaida K.I., Shimizu J., Hanajima R., Hayashi T., Terao Y.,
RA   Inomata-Terada S., Hamada M., Shirota Y., Kubota A., Ugawa Y., Koh K.,
RA   Takiyama Y., Ohsawa-Yoshida N., Ishiura S., Yamasaki R., Tamaoka A.,
RA   Akiyama H., Otsuki T., Sano A., Ikeda A., Goto J., Morishita S., Tsuji S.;
RT   "Expansions of intronic TTTCA and TTTTA repeats in benign adult familial
RT   myoclonic epilepsy.";
RL   Nat. Genet. 50:581-590(2018).
CC   -!- FUNCTION: Plays a role in RNA-mediated gene silencing by both micro-
CC       RNAs (miRNAs) and short interfering RNAs (siRNAs). Required for miRNA-
CC       dependent repression of translation and for siRNA-dependent
CC       endonucleolytic cleavage of complementary mRNAs by argonaute family
CC       proteins. As a scaffolding protein, associates with argonaute proteins
CC       bound to partially complementary mRNAs, and can simultaneously recruit
CC       CCR4-NOT and PAN deadenylase complexes. {ECO:0000269|PubMed:16284622,
CC       ECO:0000269|PubMed:16284623, ECO:0000269|PubMed:17596515,
CC       ECO:0000269|PubMed:17671087, ECO:0000269|PubMed:19056672,
CC       ECO:0000269|PubMed:19304925}.
CC   -!- SUBUNIT: Interacts with AGO2 (PubMed:16284623, PubMed:16284622,
CC       PubMed:18690212, PubMed:19304925, PubMed:19324964, PubMed:19383768).
CC       Interacts with AGO1, AGO3 and AGO4 (PubMed:19324964, PubMed:19383768).
CC       Interacts with CNOT1; the interaction is direct and mediates the
CC       association with the CCR4-NOT complex (PubMed:21981923). Interacts with
CC       ZC3H12A (PubMed:26134560). Interacts with SND1 (PubMed:28546213).
CC       {ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623,
CC       ECO:0000269|PubMed:18690212, ECO:0000269|PubMed:19304925,
CC       ECO:0000269|PubMed:19324964, ECO:0000269|PubMed:19383768,
CC       ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:26134560,
CC       ECO:0000269|PubMed:28546213}.
CC   -!- INTERACTION:
CC       Q9UL18:AGO1; NbExp=5; IntAct=EBI-2269715, EBI-527363;
CC       Q9UKV8:AGO2; NbExp=16; IntAct=EBI-2269715, EBI-528269;
CC       Q9H9G7:AGO3; NbExp=3; IntAct=EBI-2269715, EBI-2267883;
CC       Q9HCK5:AGO4; NbExp=4; IntAct=EBI-2269715, EBI-2269696;
CC       A5YKK6:CNOT1; NbExp=2; IntAct=EBI-2269715, EBI-1222758;
CC       P11940:PABPC1; NbExp=3; IntAct=EBI-2269715, EBI-81531;
CC       Q58A45:PAN3; NbExp=2; IntAct=EBI-2269715, EBI-2513054;
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-2269715, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:11950943,
CC       ECO:0000269|PubMed:13130130, ECO:0000269|PubMed:15494374,
CC       ECO:0000269|PubMed:15908945, ECO:0000269|PubMed:16284622,
CC       ECO:0000269|PubMed:16284623, ECO:0000269|PubMed:16906129,
CC       ECO:0000269|PubMed:18946079, ECO:0000269|PubMed:19056672,
CC       ECO:0000269|PubMed:19324964}. Note=Mammalian P-bodies are also known as
CC       GW bodies (GWBs). {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=TNGW1;
CC         IsoId=Q8NDV7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NDV7-2; Sequence=VSP_013294;
CC       Name=3;
CC         IsoId=Q8NDV7-3; Sequence=VSP_037287, VSP_037288, VSP_037289;
CC       Name=4;
CC         IsoId=Q8NDV7-4; Sequence=VSP_013292;
CC       Name=5;
CC         IsoId=Q8NDV7-5; Sequence=VSP_013295;
CC       Name=6;
CC         IsoId=Q8NDV7-6; Sequence=VSP_037288;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11950943,
CC       ECO:0000269|PubMed:29507423}.
CC   -!- INDUCTION: By exogenous short interfering RNA (siRNA).
CC       {ECO:0000269|PubMed:18946079}.
CC   -!- DISEASE: Epilepsy, familial adult myoclonic, 6 (FAME6) [MIM:618074]: A
CC       form of familial myoclonic epilepsy, a neurologic disorder
CC       characterized by cortical hand tremors, myoclonic jerks and occasional
CC       generalized or focal seizures with a non-progressive or very slowly
CC       progressive disease course. Usually, myoclonic tremor is the presenting
CC       symptom, characterized by tremulous finger movements and myoclonic
CC       jerks of the limbs increased by action and posture. In a minority of
CC       patients, seizures are the presenting symptom. Some patients exhibit
CC       mild cognitive impairment. FAME6 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:29507423}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Antibodies against TNRC6A are found in sera from
CC       patients with Sjoegren syndrome (SS), ataxia and sensor neuropathy
CC       diseases that developed autoantibodies against protein of the GWB
CC       structure. Autoantibodies were mapped to the GW-rich mid-part, the non-
CC       GW-rich region and the C-terminus of the protein.
CC   -!- SIMILARITY: Belongs to the GW182 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91899.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAD28525.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY035864; AAK62026.1; -; mRNA.
DR   EMBL; AJ492221; CAD37348.1; -; mRNA.
DR   EMBL; AL713750; CAD28525.2; ALT_INIT; mRNA.
DR   EMBL; AL833757; CAH56236.1; -; mRNA.
DR   EMBL; AC002565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008731; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC024324; AAH24324.2; -; mRNA.
DR   EMBL; BC068209; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U80739; AAB91438.1; -; mRNA.
DR   EMBL; AB040893; BAA95984.1; -; mRNA.
DR   EMBL; AK001773; BAA91899.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10624.2; -. [Q8NDV7-1]
DR   CCDS; CCDS81959.1; -. [Q8NDV7-6]
DR   RefSeq; NP_001317449.1; NM_001330520.1. [Q8NDV7-6]
DR   RefSeq; NP_055309.2; NM_014494.2. [Q8NDV7-1]
DR   RefSeq; XP_005255314.1; XM_005255257.4. [Q8NDV7-2]
DR   RefSeq; XP_016878642.1; XM_017023153.1. [Q8NDV7-2]
DR   PDB; 5W6V; X-ray; 2.83 A; B=1073-1094.
DR   PDBsum; 5W6V; -.
DR   SMR; Q8NDV7; -.
DR   BioGrid; 118141; 105.
DR   DIP; DIP-54489N; -.
DR   ELM; Q8NDV7; -.
DR   IntAct; Q8NDV7; 87.
DR   MINT; Q8NDV7; -.
DR   STRING; 9606.ENSP00000379144; -.
DR   iPTMnet; Q8NDV7; -.
DR   PhosphoSitePlus; Q8NDV7; -.
DR   BioMuta; TNRC6A; -.
DR   DMDM; 296452846; -.
DR   EPD; Q8NDV7; -.
DR   jPOST; Q8NDV7; -.
DR   MassIVE; Q8NDV7; -.
DR   MaxQB; Q8NDV7; -.
DR   PaxDb; Q8NDV7; -.
DR   PeptideAtlas; Q8NDV7; -.
DR   PRIDE; Q8NDV7; -.
DR   ProteomicsDB; 73061; -. [Q8NDV7-1]
DR   ProteomicsDB; 73062; -. [Q8NDV7-2]
DR   ProteomicsDB; 73063; -. [Q8NDV7-3]
DR   ProteomicsDB; 73064; -. [Q8NDV7-4]
DR   ProteomicsDB; 73065; -. [Q8NDV7-5]
DR   ProteomicsDB; 73066; -. [Q8NDV7-6]
DR   Ensembl; ENST00000315183; ENSP00000326900; ENSG00000090905. [Q8NDV7-6]
DR   Ensembl; ENST00000395799; ENSP00000379144; ENSG00000090905. [Q8NDV7-1]
DR   Ensembl; ENST00000672933; ENSP00000500125; ENSG00000288130. [Q8NDV7-6]
DR   Ensembl; ENST00000673084; ENSP00000500873; ENSG00000288130. [Q8NDV7-1]
DR   GeneID; 27327; -.
DR   KEGG; hsa:27327; -.
DR   UCSC; uc002dmm.4; human. [Q8NDV7-1]
DR   CTD; 27327; -.
DR   DisGeNET; 27327; -.
DR   EuPathDB; HostDB:ENSG00000090905.17; -.
DR   GeneCards; TNRC6A; -.
DR   HGNC; HGNC:11969; TNRC6A.
DR   HPA; HPA015305; -.
DR   HPA; HPA017869; -.
DR   MalaCards; TNRC6A; -.
DR   MIM; 610739; gene.
DR   MIM; 618074; phenotype.
DR   neXtProt; NX_Q8NDV7; -.
DR   OpenTargets; ENSG00000090905; -.
DR   PharmGKB; PA36656; -.
DR   eggNOG; ENOG410IF5S; Eukaryota.
DR   eggNOG; ENOG41110AX; LUCA.
DR   GeneTree; ENSGT00940000158180; -.
DR   InParanoid; Q8NDV7; -.
DR   KO; K18412; -.
DR   OMA; MDTGTSW; -.
DR   OrthoDB; 50428at2759; -.
DR   PhylomeDB; Q8NDV7; -.
DR   TreeFam; TF329702; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8943723; Regulation of PTEN mRNA translation.
DR   Reactome; R-HSA-8948700; Competing endogenous RNAs (ceRNAs) regulate PTEN translation.
DR   Reactome; R-HSA-8986944; Transcriptional Regulation by MECP2.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9022692; Regulation of MECP2 expression and activity.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   ChiTaRS; TNRC6A; human.
DR   GeneWiki; TNRC6A; -.
DR   GenomeRNAi; 27327; -.
DR   Pharos; Q8NDV7; Tbio.
DR   PRO; PR:Q8NDV7; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q8NDV7; protein.
DR   Bgee; ENSG00000090905; Expressed in 205 organ(s), highest expression level in cerebellar vermis.
DR   ExpressionAtlas; Q8NDV7; baseline and differential.
DR   Genevisible; Q8NDV7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IDA:MGI.
DR   GO; GO:0016442; C:RISC complex; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
DR   GO; GO:0035195; P:gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0035278; P:miRNA mediated inhibition of translation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; TAS:Reactome.
DR   GO; GO:0010628; P:positive regulation of gene expression; TAS:Reactome.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IBA:GO_Central.
DR   GO; GO:0035194; P:posttranscriptional gene silencing by RNA; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   CDD; cd12711; RRM_TNRC6A; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR019486; Argonaute_hook_dom.
DR   InterPro; IPR026805; GW182_M_dom.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR032226; TNRC6_PABC-bd.
DR   InterPro; IPR033501; TNRC6A.
DR   InterPro; IPR034924; TNRC6A_RRM.
DR   PANTHER; PTHR13020:SF28; PTHR13020:SF28; 1.
DR   Pfam; PF10427; Ago_hook; 1.
DR   Pfam; PF12938; M_domain; 1.
DR   Pfam; PF16608; TNRC6-PABC_bdg; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
**   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1; FALSE_POS.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Cytoplasm; Epilepsy;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA-binding;
KW   RNA-mediated gene silencing; Translation regulation.
FT   CHAIN           1..1962
FT                   /note="Trinucleotide repeat-containing gene 6A protein"
FT                   /id="PRO_0000081980"
FT   DOMAIN          1781..1853
FT                   /note="RRM"
FT   REGION          1..932
FT                   /note="Interaction with argonaute family proteins"
FT   REGION          254..503
FT                   /note="Sufficient for interaction with AGO1, AGO3 and AGO4"
FT   REGION          270..346
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          318..399
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          340..439
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          409..495
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          502..751
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          566..1343
FT                   /note="Sufficient for interaction with AGO1 and AGO4"
FT   REGION          1074..1144
FT                   /note="Sufficient for interaction with AGO2"
FT   REGION          1604..1622
FT                   /note="PABPC1-interacting motif-2 (PAM2)"
FT   REGION          1670..1962
FT                   /note="Sufficient for interaction with AGO2"
FT   COILED          7..54
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        93..127
FT                   /note="Gln-rich"
FT   COMPBIAS        192..365
FT                   /note="Ser-rich"
FT   MOD_RES         739
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         878
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         991
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1470
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1585
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1890
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..1801
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013292"
FT   VAR_SEQ         1..1232
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_037287"
FT   VAR_SEQ         1..253
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11950943"
FT                   /id="VSP_013294"
FT   VAR_SEQ         1..54
FT                   /note="MRELEAKATKDVERNLSRDLVQEEEQLMEEKKKKKDDKKKKEAAQKKATEQK
FT                   IK -> MAYFGGTLYWLIFSTPFLLLGL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9225980"
FT                   /id="VSP_013295"
FT   VAR_SEQ         1280..1328
FT                   /note="Missing (in isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_037288"
FT   VAR_SEQ         1611..1962
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_037289"
FT   VARIANT         185
FT                   /note="N -> K (in dbSNP:rs11639856)"
FT                   /id="VAR_057251"
FT   VARIANT         592
FT                   /note="A -> T (in dbSNP:rs6497759)"
FT                   /id="VAR_057252"
FT   VARIANT         788
FT                   /note="P -> S (in dbSNP:rs3803716)"
FT                   /id="VAR_057253"
FT   VARIANT         1268
FT                   /note="E -> K (in dbSNP:rs2112782)"
FT                   /id="VAR_057254"
FT   MUTAGEN         313
FT                   /note="W->A: Does not impair interaction with AGO2; when
FT                   associated with A-345; A-370; A-420 and A-483"
FT                   /evidence="ECO:0000269|PubMed:19324964"
FT   MUTAGEN         345
FT                   /note="W->A: Does not impair interaction with AGO2; when
FT                   associated with A-313; A-370; A-420 and A-483"
FT                   /evidence="ECO:0000269|PubMed:19324964"
FT   MUTAGEN         370
FT                   /note="W->A: Does not impair interaction with AGO2; when
FT                   associated with A-313; A-345; A-420 and A-483"
FT                   /evidence="ECO:0000269|PubMed:19324964"
FT   MUTAGEN         420
FT                   /note="W->A: Does not impair interaction with AGO2; when
FT                   associated with A-313; A-345; A-370 and A-483"
FT                   /evidence="ECO:0000269|PubMed:19324964"
FT   MUTAGEN         483
FT                   /note="W->A: Does not impair interaction with AGO2; when
FT                   associated with A-313; A-345; A-370 and A-420"
FT                   /evidence="ECO:0000269|PubMed:19324964"
FT   CONFLICT        31..34
FT                   /note="KKKK -> TEKE (in Ref. 2; CAD37348)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1375
FT                   /note="V -> VV (in Ref. 3; CAD28525)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1704
FT                   /note="S -> F (in Ref. 8; BAA91899)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1962 AA;  210297 MW;  963C054628E18592 CRC64;
     MRELEAKATK DVERNLSRDL VQEEEQLMEE KKKKKDDKKK KEAAQKKATE QKIKVPEQIK
     PSVSQPQPAN SNNGTSTATS TNNNAKRATA NNQQPQQQQQ QQQPQQQQPQ QQPQPQPQQQ
     QPQQQPQALP RYPREVPPRF RHQEHKQLLK RGQHFPVIAA NLGSAVKVLN SQSESSALTN
     QQPQNNGEVQ NSKNQSDINH STSGSHYENS QRGPVSSTSD SSTNCKNAVV SDLSEKEAWP
     SAPGSDPELA SECMDADSAS SSESERNITI MASGNTGGEK DGLRNSTGLG SQNKFVVGSS
     SNNVGHGSST GPWGFSHGAI ISTCQVSVDA PESKSESSNN RMNAWGTVSS SSNGGLNPST
     LNSASNHGAW PVLENNGLAL KGPVGSGSSG INIQCSTIGQ MPNNQSINSK VSGGSTHGTW
     GSLQETCESE VSGTQKVSFS GQPQNITTEM TGPNNTTNFM TSSLPNSGSV QNNELPSSNT
     GAWRVSTMNH PQMQAPSGMN GTSLSHLSNG ESKSGGSYGT TWGAYGSNYS GDKCSGPNGQ
     ANGDTVNATL MQPGVNGPMG TNFQVNTNKG GGVWESGAAN SQSTSWGSGN GANSGGSRRG
     WGTPAQNTGT NLPSVEWNKL PSNQHSNDSA NGNGKTFTNG WKSTEEEDQG SATSQTNEQS
     SVWAKTGGTV ESDGSTESTG RLEEKGTGES QSRDRRKIDQ HTLLQSIVNR TDLDPRVLSN
     SGWGQTPIKQ NTAWDTETSP RGERKTDNGT EAWGSSATQT FNSGACIDKT SPNGNDTSSV
     SGWGDPKPAL RWGDSKGSNC QGGWEDDSAA TGMVKSNQWG NCKEEKAAWN DSQKNKQGWG
     DGQKSSQGWS VSASDNWGET SRNNHWGEAN KKSSSGGSDS DRSVSGWNEL GKTSSFTWGN
     NINPNNSSGW DESSKPTPSQ GWGDPPKSNQ SLGWGDSSKP VSSPDWNKQQ DIVGSWGIPP
     ATGKPPGTGW LGGPIPAPAK EEEPTGWEEP SPESIRRKME IDDGTSAWGD PSKYNYKNVN
     MWNKNVPNGN SRSDQQAQVH QLLTPASAIS NKEASSGSGW GEPWGEPSTP ATTVDNGTSA
     WGKPIDSGPS WGEPIAAASS TSTWGSSSVG PQALSKSGPK SMQDGWCGDD MPLPGNRPTG
     WEEEEDVEIG MWNSNSSQEL NSSLNWPPYT KKMSSKGLSG KKRRRERGMM KGGNKQEEAW
     INPFVKQFSN ISFSRDSPEE NVQSNKMDLS GGMLQDKRME IDKHSLNIGD YNRTVGKGPG
     SRPQISKESS MERNPYFDKD GIVADESQNM QFMSSQSMKL PPSNSALPNQ ALGSIAGLGM
     QNLNSVRQNG NPSMFGVGNT AAQPRGMQQP PAQPLSSSQP NLRAQVPPPL LSPQVPVSLL
     KYAPNNGGLN PLFGPQQVAM LNQLSQLNQL SQISQLQRLL AQQQRAQSQR SVPSGNRPQQ
     DQQGRPLSVQ QQMMQQSRQL DPNLLVKQQT PPSQQQPLHQ PAMKSFLDNV MPHTTPELQK
     GPSPINAFSN FPIGLNSNLN VNMDMNSIKE PQSRLRKWTT VDSISVNTSL DQNSSKHGAI
     SSGFRLEESP FVPYDFMNSS TSPASPPGSI GDGWPRAKSP NGSSSVNWPP EFRPGEPWKG
     YPNIDPETDP YVTPGSVINN LSINTVREVD HLRDRNSGSS SSLNTTLPST SAWSSIRASN
     YNVPLSSTAQ STSARNSDSK LTWSPGSVTN TSLAHELWKV PLPPKNITAP SRPPPGLTGQ
     KPPLSTWDNS PLRIGGGWGN SDARYTPGSS WGESSSGRIT NWLVLKNLTP QIDGSTLRTL
     CMQHGPLITF HLNLPHGNAL VRYSSKEEVV KAQKSLHMCV LGNTTILAEF ASEEEISRFF
     AQSQSLTPSP GWQSLGSSQS RLGSLDCSHS FSSRTDLNHW NGAGLSGTNC GDLHGTSLWG
     TPHYSTSLWG PPSSSDPRGI SSPSPINAFL SVDHLGGGGE SM
//
